There is convincing evidence that a decreased expression of LRG1 is associated with increased fibrosis, aberrant vascular properties, and altered cardiomyocytes characteristics in ageing heart, and in failing heart induced by genetic modification, pressure overload, or hypertension (Fig. 2). This evidence concerns the gene LRG1 and hypertensive disorder.